Skip to main content

Search form

You are here

Brant Allen Inman, MD, MS

Cary N. Robertson, MD, Associate Professor
Associate Professor of Surgery
Division: 
Urology
Faculty Lab: 
Urologic Oncology Laboratory
Program: 
Urologic Oncology Fellowship
Urology Residency Program
Office: 3007 Snyderman Bldg, 905 La Salle Street, Durham, NC 27710
Campus Mail: DUMC DUMC Box 103868, Durham, NC 27710

Clinical research interests:
Clinical trials of novel diagnostic tests and therapies for genitourinary malignancies, with a strong focus on bladder cancer.

Basic science research interests:
Immune therapies for cancer, hyperthermia and heat-based treatment of cancer, molecular biology of genitourinary cancers, novel diagnostics and therapies for genitourinary cancers

Education and Training

  • Fellowship, Urologic Oncology, Mayo Clinic, 2005 - 2008
  • Residency, Urology, Universite Laval (Canada), 2001 - 2005
  • M.S., Mayo Medical School, 2011
  • M.D., University of Alberta (Canada), 2000
  • B.S., University of Alberta (Canada), 1999

In the News

Selected Grants

Publications

Wang, Yingqi, Andrew Chang, Wei Phin Tan, Joseph J. Fantony, Ajay Gopalakrishna, Gregory J. Barton, Paul E. Wischmeyer, Rajan T. Gupta, and Brant A. Inman. “Diet and Exercise Are not Associated with Skeletal Muscle Mass and Sarcopenia in Patients with Bladder Cancer..” Eur Urol Oncol, May 25, 2019. https://doi.org/10.1016/j.euo.2019.04.012.

Full Text

Lotan, Yair, Brant A. Inman, Leah Gerber Davis, Wassim Kassouf, Edward Messing, Siamak Daneshmand, Daniel Canter, et al. “Evaluation of the UroVysion™ Test to Predict Recurrence and/or Progression of Disease After BCG for Primary High Grade Non-Muscle Invasive Bladder Cancer: Results from a Prospective Multicenter Trial..” J Urol, May 23, 2019. https://doi.org/10.1097/JU.0000000000000355.

Full Text

Meleis, Laura, Russell Moore, Brant A. Inman, and Michael R. Harrison. “Retrospective analysis of the efficacy and safety of neoadjuvant gemcitabine and cisplatin in muscle-invasive bladder cancer..” J Oncol Pharm Pract, May 12, 2019. https://doi.org/10.1177/1078155219845434.

Full Text

Soria, Francesco, Laura-Maria Krabbe, Tilman Todenhöfer, Jakub Dobruch, Anirban P. Mitra, Brant A. Inman, Kilian M. Gust, Yair Lotan, and Shahrokh F. Shariat. “Molecular markers in bladder cancer..” World J Urol 37, no. 1 (January 2019): 31–40. https://doi.org/10.1007/s00345-018-2503-4.

Full Text

Terlecki, R. P., N. L. Miller, and B. A. Inman. “Trends in Urological Referral Patterns: A Study of Community and University Urologists in the United States.” Urology Practice 5, no. 6 (November 1, 2018): 480–88. https://doi.org/10.1016/j.urpr.2017.11.003.

Full Text

Ingersoll, Molly A., Xue Li, Brant A. Inman, John W. Greiner, Peter C. Black, and Rosalyn M. Adam. “Immunology, Immunotherapy, and Translating Basic Science into the Clinic for Bladder Cancer..” Bladder Cancer (Amsterdam, Netherlands) 4, no. 4 (October 29, 2018): 429–40. https://doi.org/10.3233/BLC-180175.

Full Text

Gopalakrishna, Ajay, Andrew Chang, Thomas A. Longo, Joseph J. Fantony, Michael R. Harrison, Paul E. Wischmeyer, and Brant A. Inman. “Dietary patterns and health-related quality of life in bladder cancer survivors..” Urol Oncol 36, no. 10 (October 2018): 469.e21-469.e29. https://doi.org/10.1016/j.urolonc.2018.06.001.

Full Text

Flaig, Thomas W., Philippe E. Spiess, Neeraj Agarwal, Rick Bangs, Stephen A. Boorjian, Mark K. Buyyounouski, Tracy M. Downs, et al. “NCCN Guidelines Insights: Bladder Cancer, Version 5.2018..” J Natl Compr Canc Netw 16, no. 9 (September 2018): 1041–53. https://doi.org/10.6004/jnccn.2018.0072.

Full Text

Liem, Esmee I. M. L., Michael McCormack, Eddie S. Y. Chan, Yoshiyuki Matsui, Petrisor Geavlete, Young D. Choi, Theo M. de Reijke, et al. “Monopolar vs. bipolar transurethral resection for non-muscle invasive bladder carcinoma: A post-hoc analysis from a randomized controlled trial..” Urol Oncol 36, no. 7 (July 2018): 338.e1-338.e11. https://doi.org/10.1016/j.urolonc.2018.03.015.

Full Text

Aminsharifi, Alireza, Steven C. Brousell, Andrew Chang, Juan León, and Brant A. Inman. “Heat-targeted drug delivery: A promising approach for organsparing treatment of bladder cancer.THERMODOX®..” Arch Esp Urol 71, no. 4 (May 2018): 447–52.

Scholars@Duke

Pages